1,514 Shares in CME Group Inc. (NASDAQ:CME) Acquired by Corton Capital Inc.

Corton Capital Inc. purchased a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 1,514 shares of the financial services provider's stock, valued at approximately $352,000.

A number of other large investors have also recently modified their holdings of the business. SJS Investment Consulting Inc. lifted its position in CME Group by 570.6% in the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock valued at $26,000 after purchasing an additional 97 shares during the last quarter. New Age Alpha Advisors LLC lifted its position in CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 43 shares during the last quarter. Financial Life Planners bought a new stake in CME Group in the fourth quarter valued at approximately $32,000. Knuff & Co LLC bought a new stake in CME Group in the fourth quarter valued at approximately $33,000. Finally, Fortitude Family Office LLC lifted its position in CME Group by 120.3% in the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider's stock valued at $35,000 after purchasing an additional 83 shares during the last quarter. Institutional investors own 87.75% of the company's stock.

Analyst Ratings Changes

Several brokerages recently weighed in on CME. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $269.00 price target on shares of CME Group in a research note on Thursday, April 3rd. UBS Group increased their target price on CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a research note on Friday, April 25th. Raymond James raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target on the stock in a report on Monday, March 10th. Morgan Stanley increased their target price on CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a report on Thursday, April 24th. Finally, Oppenheimer increased their target price on CME Group from $269.00 to $279.00 and gave the company an "outperform" rating in a report on Friday, April 11th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $256.80.

Insider Buying and Selling at CME Group

In other news, insider Julie Winkler sold 11,592 shares of the business's stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the sale, the insider now owns 21,885 shares in the company, valued at approximately $5,453,085.45. The trade was a 34.63% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Dennis Suskind sold 1,000 shares of CME Group stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total transaction of $271,280.00. Following the completion of the transaction, the director now directly owns 2,915 shares in the company, valued at $790,781.20. The trade was a 25.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 34,726 shares of company stock worth $8,975,813 over the last three months. Insiders own 0.30% of the company's stock.

CME Group Stock Performance

Shares of CME stock traded down $14.77 during trading hours on Monday, hitting $269.58. The company's stock had a trading volume of 2,168,281 shares, compared to its average volume of 2,155,844. The company has a 50 day moving average of $264.47 and a 200 day moving average of $245.78. The stock has a market cap of $97.14 billion, a PE ratio of 27.90, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $287.36.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The company had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The firm's revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the prior year, the business posted $2.50 earnings per share. On average, sell-side analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.85%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's dividend payout ratio is presently 50.30%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.